醫學事務聲譽（美國）－前列腺癌

根據這項針對 100 名美國腫瘤學家的最新調查，一些主要品牌的前列腺癌醫療事務團隊的表現在幾個關鍵領域還有待提高。該報告揭示了醫生認為哪些方面做得好、他們希望哪些方面做得更好以及他們不滿意的原因。了解醫療事務如何滿足治療多灶性前列腺癌的醫生的高期望。比較各領先公司的醫療事務團隊在前列腺癌治療的當前表現。

報告內容

• 醫師與醫療事務團隊的互動頻率是多少？這種頻率是增加還是減少？
• 醫師目前如何使用醫學事務團隊提供的服務？
• 醫療事務支援的哪些方面對醫師來說最重要，他們對所提供的支援有多滿意？
• 醫師和醫療事務團隊之間希望進行哪種類型的互動？互動頻率如何？
• 醫療事務團隊滿足醫師需求的程度如何？
• 醫療事務團隊針對某品牌所設定的目標是否表現不佳或超乎預期？
• 未來如何改善醫學事務服務以更滿足醫師的需求？
• 競爭對手的醫療事務團隊在哪些方面最薄弱，哪些方面最強？

According to this latest survey of 100 US oncologists, the performance of prostate cancer medical affairs teams for some high profile brands still has a way to go in some key areas. Find out what physicians think is done well; what they want to see more of; and why some are dissatisfied. This report reveals how medical affairs can better meet the high expectations of physicians treating multiple prostate cancer. It compares the current performance of medical affairs teams for leading treatments for prostate cancer from various companies.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Methodology

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.